600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01575

Synthetic patientNBL-101 · Day 108 · 35–44 · F · baseline S17Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S17

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Nutritional resilience-3
  • Toxicity+3
  • Inflammatory activity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    21.7/100
    worsening · +5.8 vs previous 14 d
    Toxicity
    Blood
    16.8/100
    improving · -2.3 vs previous 14 d
    Sleep quality
    Wearable
    34/100
    stable · -1.4 vs previous 14 d
    Energy level
    Daily log
    5.6/10
    stable · -0.2 vs previous 14 d
    Stress level
    Daily log
    3.2/10
    stable · -0.0 vs previous 14 d
    Steps
    Wearable
    2,657
    worsening · -390 vs previous 14 d
    Adherence
    Companion
    90.9 %
    worsening · -4.6 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading drifting · 87 from the failing basin, 9 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Alcohol (supports)
      perturbation · steering +2.4
    • Alcohol
      supporter · GI -1.6 next day
    Main detractors to watch
    • Poor metabolizer
      hidden · steering -12.7
    • IL6 high-expression variant
      hidden · steering -7.3
    • Spicy / capsaicin
      perturbation · steering -5.5
    • Antibiotic course
      perturbation · steering -4.7
    • Spicy / capsaicin
      detractor · GI +3.3 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Spicy / capsaicin
      +3.3detractor · 95%
    • Alcohol
      -1.6supporter · 57%
    • Dietary fat load
      +1.5no signal · 35%
    • Insoluble fibre
      -1.2no signal · 32%
    • Histamine load
      -0.1no signal · 15%
    • Simple carbohydrates
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery ↑65
      • WearableResting HR 74 bpm
      • Wearable2,657 steps/day
      • WearableShort sleep window
    • Drug metabolism and exposure ↑40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Inflammatory signalling ↓25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity ↓10
      • WearableSleep 6.0 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 3.2 · butyrate capacity 49/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    58 ms
    Sleep
    6.1 h
    Steps
    3,672
    Resting HR
    73 bpm
    Daily log: GI score 22, nutritional resilience 57, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0176647%S05AD-05no change90
    P-0180427%S19AD-05improved61
    P-0154125%S09AD-05no change43
    P-0132950%S08BR-03improved79
    P-0167743%S05BR-03no change86
    P-0149539%S07BR-03improved85
    P-0168926%S13BR-03no change50
    P-0165440%S08CR-01improved85
    P-0143025%S05CR-01improved54
    P-0147942%S15DT-01improved84
    P-0185539%S04DT-01improved73
    P-0172430%S10DT-01improved63